Pre-Treatment Loss to Follow-up of Patients with Bacilloscopy-Confirmed Pulmonary Tuberculosis in the National Center for the Fight Against Tuberculosis and Respiratory Diseases in Niamey
Abstract
Context: Pre-treatment loss of follow-up (PTLFU) represents a major problem that hinders the management of tuberculosis. The objective of this study is to determine the prevalence of lost to follow-up patients diagnosed with smear-positive pulmonary tuberculosis (SPPT) and referred to other TB screening and treatment centers (TBSTC).
Method: This was a prospective, descriptive and analytical study conducted over a six month between March and August 2019, in patients diagnosed with smear-positive pulmonary tuberculosis at NCFATRD and referred to Niamey and Tillaberi centers. The chi-square text was used with a significance level of P ≤ 0.05.
Results: 743 patients were diagnosed with SPPT, and 346 were referred to the TBSTC located in Niamey and Tillaberi cities. The prevalence of loss of follow-up before treatment in both Niamey and Tillaberi cities was 14.45% (50/343). Male represented 82% (41) of the cases with a sex ratio of 4.55. The mean age of our patients was 41.04 years. Patients not attending school and those with primary education represented the majority with 30% each. The majority of PTLFU (95.66%) were new cases of TB. Nearly half (42%) of PTLFU had traveled a distance of 6 to 15 km to get the TB screening. During the phone call follow up, we were able to reach only 12 patients (24%) of which 7 (14%) were deceased.
Conclusion : the prevalence of PTLFU is high, therefore there is a need to reinforce the research of lost to follow up patients in order to improve tuberculosis control and management.
Downloads
Metrics
References
2. Horo K, Kouassi AB, Brou Gode CV, Horo K, Ahui JMB, Diaw A, Kone-Konate F, Toure K, Gnaze AZ, N’Gom SA, Koffi BN, Aka-Danguy A (2011). Facteurs prédictifs du statut « perdus de vue » au cours du traitement de la tuberculose. Rev Mal Respir, 28 (7), 894-902.
3. Organisation Mondiale de la Santé. Stratégie Halte à la tuberculose. Récupéré de http://www.who.int/tb/strategy/stop_ tb_strategy/fr/
4. Rao NA, Anwer T, Saleem M (2009). Magnitude of initial default in pulmonary tuberculosis. The Journal of the Pakistan Medical Association,59 (4), 223-5.
5. Sanchez-Padilla E, Merker M, Becker P, Jochims F, Dlamini T, Khan P, Bonnet M, Niemann S (2015). Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland. The New England Journal of Medecine, 372 (12), 1181-2.
6. Pherson PM, Houben RM, Glynn JR, Corbett EL, Kranzer K (2014). Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and metaanalysis. Bull World Health Organ, 92(2),126-38.
7. Programme National de Lutte contre la Tuberculose u Niger. Rapport annuel PNLT Niger, année 2016.Page 14.
8. Beena ET, Subbaraman R, Sellappan S, Suresh C, Lavanya J, Lincy S, Raja Al, Javeed D, Kokila S, Arumugam S, Swaminathan S, Maye KH (2018). Pretreatment loss to follow-up of tuberculosis patients in Chennai, India: a cohort study with implications for health systems strengthening. BMC Infect Dis,18 (1),142
9. Programme National de Lutte contre la Tuberculose (PNLT) du Niger. Rapport de la revue épidémiologique du PNLT 2017. Page 17.
10. Programme National de Lutte contre la Tuberculose du Niger. Rapport des activités 2020. Page 26.
11. Programme National de Lutte contre la Tuberculose du Niger. Rapport des activités 2019. Page 19
12. Wali A, Kumar AMV, Hinderaker SG, Heldal E, Qadeer E, Fatima R, Ulla A,Safdar N, Yaqoob A, Anwar K, UI Haq M (2017). Pre-treatment loss to follow-up among smear positive TB patients in tertiary hospitals, Quetta, Pakistan. Public Health Action, 7(1),21-5.
13. Botha E, Den Boon S, Verver S Dunbar R, Laurent KA, Bosman M, Enarson M, Toms NB (2008). Initial default from tuberculosis treatment: how often does it happen and what are the reasons? Int J Tuberc Lung Dis,12 (7),820-3.
14. Chukwu J N, Ikebudu N, Meka AO, Nwafor CC, Ogbudebe CJ, Onyonoro UU, Oshi DC, Uchenna OU (2012). Pattern and magnitude of treatment delay among TB patients in five states in southern Nigeria. Ann Trop Med Public Health, 5(2),173-177.
15. Squire SB, Belaye AK, Kashot A, Salanipini FML, Mundy CJF, Théobald S, Kem J (2005). « Lost » smearpositive pulmonary tuberculosis cases: where are they and why did we lose them? Int J Tuberc Lung Dis,9 (1), 25-31.
16. Creek TL, Lockman S, Kenyon T. A, Makhoa M, Chimidza N, Moëti T, Sarpong BB, Binkin NJ, Tappero JW (2000). Completeness and timeliness of treatment initiation after laboratory diagnosis of tuberculosis in Gaborone, Botswana. Int J Tuberc Lung Dis, 4(10), 956-61.
17. Sai Babu B, Satyanarayana AVV, Venkateshwaralu G, Ramakrishna U, Vikram P, Sahu S, Sahu S, Wares F, Dewan PK, Santosha K, Jyoti J, Chethana R, Neelima t, Vinod P, Yogesh M, Chauhan LS (2008). Initial default among diagnosed sputum smear-positive pulmonary tuberculosis patients in Andhra Pradesh, India. Int J Tuberc Lung Dis,12(9),1055-8.
18. Khan SM, Shoaib K,Godfrey-Faussett P (2009). Default during TB diagnosis: Quantifying the problem. Trop Med Int Health TM IH, 14(12),1437-41.
19. Ko Ko H, Nang Thu Thu K , Ajay MV K, Khine Wu Yee K, Myo Minn OO, Thandar T, Vu V, Aung ST (2019). Pretreatment loss to follow-up and treatment delay among bacteriologically-confirmed tuberculosis patients diagnosed in Mandalay Region ; Myanmar. Tropical medicine and health, 47(30), 2-10.
20. Onyoh EF, Kuaban C, Lin HH (2018). Pre-Treatment loss to follow-up of pulmonary tuberculosis patients in two regions of Cameroon. Int J Tuberc Lung Dis,22(4), 378-384.
21. Syed Mustafa A, Farah N, Arif N, Irum F, Kerri V, Mohammed I, Anjum N, Rashid A, Haider GR, Khan MA, Aamir J (2018). Loss-to-follow-up and delay to treatment initiation in Pakistan’s national tuberculosis control programme. BMC Public Health,18 (1),335.
22. Mehra D, Kaushik RM, Kaushik R (2013). Initial default among sputum-positive pulmonary TB patients at a referral hospital in Uttarakhand, India. Trans R Soc Trop Med Hyg,107 (9),558-65.
23. Organisation Mondiale de la Santé. Tuberculose : profils de pays Récupéré de http://www.who.int/tb/country/data/ profiles/fr/. Consulté le 03 décembre 2020 à 11h.
24. Centre National Anti Tuberculeux du Niger. Rapport annuel CNAT 2017. Page 56.
25. Institut Nationale de la Statistique du Niger (INSN). Annuaire statistique régionale de Niamey 2013 - 2017. Edition 2018. Page 22-31.
26. Organisation Mondiale de la Santé. Stratégie Halte à la tuberculose. Récupéré de:http://www.who.int/tb/strategy/stop_ tb_strategy/fr/
27. Diop F P, Gandaho T, Karamoko D, Soucat A, Vaillancourt DA (2004). Sante et pauvrete au Niger : vers les objectifs du Millenaire pour le Developpement - rapport analytique sante pauvrete (French). Africa Region Human Development working paper series, no. 51Washington, D.C. : World Bank Group. Récupéré de http://documents.worldbank.org/curated/en/222711468096267627/Sante-et-pauvrete-au-Niger-vers-les-objectifs-du-Millenaire-pour-le-Developpement-rapport-analytique-sante-pauvrete
Copyright (c) 2024 Assiatou Gagara Issoufou Madougou, Mahamadou Bassirou Souleymane, Alphazazi Soumana, Souleymane Halidou Moussa
This work is licensed under a Creative Commons Attribution 4.0 International License.
.jpg)
